期刊文献+

多囊卵巢综合征患者肾上腺雄激素水平与胰岛素抵抗的关系 被引量:1

The relationship of adrenal androgen level and insulin resistance in polycystic ovary syndrome patients
原文传递
导出
摘要 目的探讨多囊卵巢综合征(PCOS)患者肾上腺源性雄激素水平与胰岛素抵抗的关系。方法对22名正常女性和85例PCOS患者行促肾上腺皮质激素(ACTH)兴奋试验,将PCOS患者分为高反应组(HR-PCOS)和正常反应组(NR-PCOS)。用放射免疫分析法检测血清促黄体生成素与卵泡刺激素(LH/FSH)比值、雌二醇、睾酮、孕酮,测定ACTH兴奋试验前后(Orain和60min)血清17-羟孕酮(17-OHP)、硫酸脱氢表雄酮(DHEAS)、雄烯二酮(AD)、皮质醇,测定稳态模型下胰岛素抵抗指数(HOMA-IR),测量体质量指数(BMI)、腰臀围比。结果在85例PCOS患者中,有20例的17-OHP水平高于正常,为HR-PCOS组,其余65例反应正常,为NR-PCOS组。基本情况比较:HR-PCOS组和NR-PCOS组的MBI及腰臀围比均显著高于对照组(MBI:X^2=13.874,14.512,腰臀围比:X^2=12.607,15.153,P均〈0.05),HR-PCOS组和NR-PCOS组间差异无统计学意义(X^2=4.801,5.362,P〉0.05);激素水平比较:HR-PCOS组和NR-PCOS组的LH/FSH比值、雌二醇显著高于对照组(LH/FSH:X^2=18226,16.327,雌二醇:矿=17334,19261,P均〈0.01),HR.PCOS组和NR-PCOS组间差异无统计学意义;HR—PCOS组血清总睾酮显著高于NR-PCOS组(X^2=12.274,P〈0.05),HR-PCOS组和NR-PCOS组均高于对照组(X2=20.314,18.492,P均〈0.01);ACTH兴奋试验前后HR-PCOS组17-OHP和DHEAS显著高于NR-PCOS组和对照组(17.OHP:X^2=18.063,19.214.DHEAS:X^2=17.358,19.355,P均〈0.01),而NR-PCOS组与对照组间差异无统计学意义(X^2=4.109,4.362,P均〉0.05);AD在ACTH兴奋试验前后HR-PCOS组和NR-PCOS组均高于对照组(X^2=14.062,16.549,P均〈0.05),而HR-PCOS组和NR-PCOS组间差异无统计学意义(X^2=5.541,P〉0.05);血清皮质醇在ACTH兴奋试验前后各组间差异无统计学意义;HR-PCOS组和NR-PCOS组的HOMA.IR均显著高于对照组(X^2=19.263,21.482,P均〈0.01),且HR-PCOS组显著高于NR-PCOS组(X^2=13.582,P均〈0.05)。结论部分PCOS患者存在肾上腺雄激素亢进并对ACTH反应性增强,其肾上腺雄激素的水平可能与胰岛素抵抗有关。 Objective To investigate the relationship between adrenal androgen level and insulin resistance in polycystic ovary syndrome(PCOS) patients. Method Twenty-two healthy women and 85 PCOS patients were underwent adrenocorticptropic hormone(ACTH) stimulation test, and 85 PCOS patients weredivided into high response-polycystic ovary syndrome(HR-PCOS) group and normal response-polycystie ovary syndrome (NR-PCOS)group. The ratio of serum luteinizing hormone to follicle stimulating hormone(LH/ FSH), estradiol(E2), testosterone(T) and progestin(P) were tested by radioimmunoassay method. 17-hydroxy-progesterone(17-OHP), dehydroepiandros-teronesulfate(DHEAS) and androsterone(AD) was tested at 0 and 60 rain after an ACTH stimulation test. Body mass index(BMI), waist-to-hip-circumference radio(WHR) and homeostasis modes of assessment for insulin resistence index(HOMA-IR) were also measured. Results There were 20 cases that 17-OHP levels were higher than normal(HR-PCOS), the other 65 cases were NR-PCOSgroup. MBI and WHR(MBI :X^2=13.874,14.512,WHR:X^2=12.607,15.153,P all〈0.05) of HR-PCOS group and NR-PCOS group were,, significantly higher than control group, but there had no significant difference between the two PCOS groups(X^2=4.801,5.326, P all〉0.05). HR-PCOS group and NR-PCOS group were significantly higher than the control group for LH/FSH and estradiol (LH/FSH :X^2= 18.226,16.327, E2:X^2=17.334,19.261 ,Pall〈0.05), but there had no significant difference between the two PCOS groups. Serum T of HR-PCOS group was significantly higher than control group(X^2=12.274, P 〈0.01), HR-PCOS group and NR-PCOS group were higher than control group (X^2=20.314, 18.492, P all〈0.01 ). 17-OHP and DHEAS of HR-PCOS group weresignificantly higher than NR-PCOS group and control group before and after ACTH stimulation test(17-OHP: X^2=lS.063,19.214,DHEAS:X^2=17.358,19.355, P all〈0.01). But there had no differences between NR-PCOS group and control group(X^2=4.109, 4.362, P all〉0.05). AD of HR-PCOS group and NR-PCOS group were higher than control group before and after the ACTH stimulation test (X^-14.062, 16.549, P all〈0.05). However,there had no differences(X^2=5.541, P〉0.05) between the two PCOS groups. Serum cortisol was no difference between HR-PCOS, NR-PCOS and control groups before and after stimulation test. HOMA-IR of HR-PCOS group and NR-PCOS group were higher than control group(X^2=19.263,21.482, P all〈0.01), and HR-PCOS group is higher than NR-PCOS group(X^2=13.582, P〈0.05). Conclusions There have significantly higher basal and ACTH-stimulated level of adrenal androgen hyperresponsiveness in PCOS patients. Adrenal androgen level appears to be closely associated with insulin resistance in PCOS patients.
出处 《国际放射医学核医学杂志》 2011年第6期358-361,共4页 International Journal of Radiation Medicine and Nuclear Medicine
关键词 多囊卵巢综合征 放射免疫分析 肾上腺皮质激素类 胰岛素抗药性 Polycystic ovary syndrome Radioimmunoassay Adrenal cortex hormones Insulinresistance
  • 相关文献

参考文献9

  • 1Kunmr A, Woods KS, Bartulucci AA, et al. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol(Oxf), 2005, 62(6) :644-649.
  • 2Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Work-shop Group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystie ovary syndrome. Fertil Steril, 2004, 81(2): 19-25.
  • 3Yildiz BO, Azziz R. The adrenal and polycystic ovary syndrome. Rev Endocr Metab Disord, 2007, 8(4): 331-342.
  • 4Ehrmann DA. Polycystic ovary" syndrome. N Engl J Med, 2005, 352 (4): 1223-1236.
  • 5New MI, Lorensen F, lerner AJ, et al. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab, 1983, 57(2): 320-326.
  • 6韩晓芬,钟雪梅.多囊卵巢综合征胰岛素抵抗的研究进展[J].西南军医,2009,11(1):76-78. 被引量:10
  • 7陶弢,刘伟,杨洁谨,毛秀英,成琦,周佳雯,陈雅雯.多囊卵巢综合征患者下丘脑-垂体-肾上腺轴改变与胰岛素抵抗的关系[J].中华内分泌代谢杂志,2010,26(5):368-369. 被引量:17
  • 8Vrbikova J, Hill M, Dvorakova K, et al. Flutamide suppresses adrenal steroidogenesis but has no effect on insulin resistance and secretion and lipid levels in overweight women with polycystic ovary syndrome. Gynecol Obstet Invest, 2004, 58( 1 ): 36-41.
  • 9Guido M, Romualdi 13, Suriano R, et al. Effect of pioglitazone treatment on the adrenal androgen response to eorticotrophin in obese patients with polycystic ovary syndrome. Hum Reprod, 2004, 19(3 ) : 534-539.

二级参考文献10

  • 1Ovalle F,Azziz R.Insulin resistance,polycystic ovary syndrome,and type 2 diabetes mellitus.Fertil Steril,2002,77:1095-1105.
  • 2Andrews RC,Herlihy O,Livingstone DE,et al.Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance.J Clin Endocrinol Metab,2002,87:5587-5593.
  • 3Kousta E.Premature adrenarche leads to polycystic ovary syndrome? Long-term consequences.Ann N Y Acad Sci,2006,1092:148-157.
  • 4Stener-Victorin E,Ploj K,Larsson BM,et al.Rats with steroid-induced polycystic ovaries develop hypertension and increased sympathetic nervous system activity.Reprod Biol Endocrinol,2005,3:44.
  • 5Invitti C,De Martin M,Delitala G,et al.Altered morning and nighttime pulsatile corticotropin and cortisol release in polycystic ovary syndrome.Metabolism,1998,47:143-148.
  • 6Anisman H,Kelly O,Hayley S,et al.Acoustic startle and fear potentiated startle in rats selectively bred for fust and slow kindling rates:relation to monoamine activity.Eur J Nenrosci,2000,12:4405-4416.
  • 7陈名道 邝安堃 丁霆.男性糖尿病患者血浆性激素及其临床意义的初步探讨[J].中华内科杂志,1982,21:67-69.
  • 8Majedah Al-Azemi,Florence E. Omu,Alexander E. Omu. The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome[J] 2004,Archives of Gynecology and Obstetrics(4):205~210
  • 9茅江峰(译者),伍学焱(审校者).述评:多囊罗日巢综合征、生物标志和二甲双胍:研究、风险及现状[J].中华内分泌代谢杂志,2008,24(3):325-326. 被引量:8
  • 10李江源(译),童伟(审校).多囊卵巢综合征、炎症、他汀类:我们的目标正确吗?[J].中华内分泌代谢杂志,2009,25(3):333-334. 被引量:3

共引文献25

同被引文献39

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部